Article
Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients.
American journal of hematology - 1 Nov 2021
Loscocco Giuseppe G, Guglielmelli Paola, Gangat Naseema, Rossi Elena, Mannarelli Carmela, Betti Silvia, Maccari Chiara, Ramundo Francesco, Jadoon Yamna, Gesullo Francesca, Ceglie Sara, Paoli Chiara, Pardanani Animesh, De Stefano Valerio, Tefferi Ayalew, Vannucchi Alessandro M
Abstract excerpt
The current retrospective study involving a total of 1607 patients was designed to identify clinical and molecular variables that were predictive of inferior myelofibrosis-free survival (MFS) in WHO-defined essential thrombocythemia (ET), utilizing three independent patient cohorts: University of Florence, Italy (n = 718); Mayo Clinic, USA (n = 479) and Policlinico Gemelli, Catholic University, Rome, Italy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.